Key Points
- Yvonne Hui sold 10,063 shares of Phreesia at an average price of $9.08 on April 16 under a pre-arranged Rule 10b5-1 plan to cover tax withholding from vested awards, reducing her position by ~27.9% to 25,991 shares (≈$236k).
- Phreesia posted a Q1 EPS miss ($0.02 vs. $0.07 expected) despite revenue rising 15.9% year-over-year; analysts have cut targets though the consensus remains a "Moderate Buy" with an average price target of $20.82, while the stock trades near $9 (52-week range $7.77–$32.76).
Phreesia, Inc. (NYSE:PHR - Get Free Report) insider Yvonne Hui sold 10,063 shares of the company's stock in a transaction that occurred on Thursday, April 16th. The shares were sold at an average price of $9.08, for a total value of $91,372.04. Following the transaction, the insider directly owned 25,991 shares of the company's stock, valued at $235,998.28. The trade was a 27.91% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards.
Phreesia Price Performance
Shares of PHR stock opened at $9.18 on Friday. The company has a debt-to-equity ratio of 0.41, a quick ratio of 1.53 and a current ratio of 1.53. Phreesia, Inc. has a fifty-two week low of $7.77 and a fifty-two week high of $32.76. The firm has a market cap of $557.47 million, a P/E ratio of 305.83 and a beta of 0.86. The business's 50 day moving average price is $10.94 and its 200-day moving average price is $16.30.
Phreesia (NYSE:PHR - Get Free Report) last announced its quarterly earnings results on Monday, March 30th. The company reported $0.02 EPS for the quarter, missing analysts' consensus estimates of $0.07 by ($0.05). The business had revenue of $127.07 million during the quarter, compared to analysts' expectations of $126.75 million. Phreesia had a return on equity of 3.23% and a net margin of 0.48%.The business's revenue was up 15.9% compared to the same quarter last year. During the same period in the previous year, the business earned ($0.11) EPS. On average, equities research analysts anticipate that Phreesia, Inc. will post -1.1 earnings per share for the current year.
Wall Street Analyst Weigh In
PHR has been the subject of a number of research reports. BMO Capital Markets decreased their price target on shares of Phreesia from $32.00 to $14.00 and set an "outperform" rating for the company in a research note on Tuesday, March 31st. Zacks Research cut Phreesia from a "strong-buy" rating to a "hold" rating in a research report on Tuesday, January 6th. JPMorgan Chase & Co. reiterated a "neutral" rating and set a $16.00 target price (down from $24.00) on shares of Phreesia in a report on Tuesday, March 31st. DA Davidson decreased their target price on Phreesia from $35.00 to $30.00 and set a "buy" rating for the company in a research report on Friday, January 23rd. Finally, Robert W. Baird restated a "neutral" rating and issued a $10.00 target price (down from $25.00) on shares of Phreesia in a research note on Tuesday, March 31st. Twelve analysts have rated the stock with a Buy rating, six have assigned a Hold rating and one has issued a Sell rating to the company's stock. Based on data from MarketBeat, the stock has an average rating of "Moderate Buy" and a consensus price target of $20.82.
Read Our Latest Stock Analysis on PHR
Institutional Trading of Phreesia
Hedge funds and other institutional investors have recently made changes to their positions in the stock. Raymond James Financial Inc. increased its position in Phreesia by 2.7% during the 2nd quarter. Raymond James Financial Inc. now owns 14,049 shares of the company's stock valued at $400,000 after buying an additional 375 shares in the last quarter. Diversified Trust Co increased its holdings in shares of Phreesia by 1.7% during the third quarter. Diversified Trust Co now owns 45,822 shares of the company's stock valued at $1,078,000 after acquiring an additional 780 shares in the last quarter. Alliancebernstein L.P. raised its position in shares of Phreesia by 1.3% in the 3rd quarter. Alliancebernstein L.P. now owns 62,712 shares of the company's stock worth $1,475,000 after purchasing an additional 812 shares during the last quarter. Van ECK Associates Corp boosted its stake in Phreesia by 78.7% in the 4th quarter. Van ECK Associates Corp now owns 2,502 shares of the company's stock worth $42,000 after purchasing an additional 1,102 shares in the last quarter. Finally, Arizona State Retirement System grew its position in Phreesia by 8.1% during the 3rd quarter. Arizona State Retirement System now owns 17,608 shares of the company's stock valued at $414,000 after purchasing an additional 1,313 shares during the last quarter. Hedge funds and other institutional investors own 92.10% of the company's stock.
Phreesia Company Profile
(
Get Free Report)
Phreesia, Inc (NYSE: PHR) is a provider of patient intake management solutions designed to streamline front-office workflows for healthcare organizations. The company's cloud-based platform digitizes patient registration, appointment scheduling, insurance verification, consent documentation and payment collection through touchscreen kiosks, tablets and mobile devices. By replacing paper forms and manual processes, Phreesia enhances data accuracy, reduces administrative burden and improves the patient experience.
Founded in 2000 by Chaim Indig and headquartered in Burlington, Massachusetts, Phreesia offers a modular software suite that integrates with electronic medical record (EMR) and practice management systems.
Further Reading
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].
